Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » FDA clears Biomet’s hip implant | Regulatory roundup

FDA clears Biomet’s hip implant | Regulatory roundup

By

Clearances roundup

Biomet Inc. received FDA 510(k) clearance for its new hip replacement device.

Warsaw, Ind.-based company said its Active Articulation E1 dual mobility hip system is an implant option for orthopedic surgeons performing hip replacement surgery.

The "dual mobility" design "utilizes a small femoral head that articulates within polyethylene. The large polyethylene bearing, when triggered, acts as a large head bearing that articulates within a metal cup," according to the company.

"The [system] provides an excellent combination of wear resistance and implant stability," Biomet U.S. orthopedics division president Jon Serbousek said in prepared remarks.

The company is competing against the likes of Stryker Corp. (NYSE:SYK) and Zimmer Holdings Inc. (NYSE:ZHM), whose hip implants orthopedic surgeons gave high marks to in a recent survey.

Biomet reported losses of $11.6 million on sales of $678.0 million during the three months ended Feb. 28 — the company’s third quarter. That compares with losses $3.1 million on sales of $669.8 million during the same period ending February 28, 2010.

Here’s a roundup of companies announcing clearances and approvals from the Food & Drug Administration and foreign regulatory agencies. Check out MassDevice’s compilation of the latest regulatory news for additional clearances and approvals.

  • K2M wins 510(k) for Everest spinal system
    K2M Inc. received 510(k) clearance from the FDA to market the EVEREST Degenerative Spinal System, a versatile top-loading polyaxial pedicle screw system featuring the ability to accommodate multiple levels of fixation rigidity to help surgeons individualize patient care. The system provides for both titanium and cobalt chrome rods of two different diameters, 5.5 and 6.0 mm, limiting inventory and increasing adaptability.
    Read more

  • Biotronik lands FDA approval for Evia pacemaker portfolio expansion
    BIOTRONIK announced FDA approval of the new Estella and Effecta pacemakers, as well as advanced new features and technologies for the Evia pacemaker family.
    Read more

  • Acousticon wins FDA clearance for hearing aid tech
    A new all-in-one hearing aid fitting system received 510(k) clearance. Acousticon, the Durham, N.C.-based American subsidiary of German firm Acousticon GmbH, announced that the FDA cleared its ACAM-5 system. ACAM-5 combines hardware and software into a system that helps audiologists understand the severity of a patient’s hearing loss and optimize the fit of a hearing aid to the hearing needs of each patient, reports MedCity News.
    Read more

  • Sound Surgical wins FDA clearance for fat removal system
    Sound Surgical Technologies announced that the PowerX Lipo System has been cleared for use by the FDA. A new power-assisted liposuction device, the PowerX System combines a rotational handpiece and multiple user settings to allow physicians to utilize the system for different body contouring applications – from gentle, superficial work to more aggressive, large volume fat removal.
    Read more

  • FDA approves updated indication for Si-Bone’s iFuse implant
    SI-BONE Inc., a medical device company that is pioneering the use of a minimally invasive surgical (MIS) device to treat the sacroiliac (SI) joint announced the FDA approved a major modification to the existing product label. The Approval targets the use of iFuse Implant System for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis. FDA-OSDB worked with SI-BONE Inc. to arrive at a more accurate description of the intended use of the iFuse System, the company said.
    Read more

  • Varian wins Chinese approval for image-guided cancer treatment system
    Varian Medical Systems Inc. (NYSE:VAR) announced that the Chinese State Food and Drug Administration (SFDA) has approved its TrueBeam system for image-guided radiotherapy. TrueBeam is a fully-integrated system designed from the ground up to treat tumors with great speed and accuracy — including tumors that move during treatment as the patient breathes in and out.
    Read more

  • VeraLight wins Health Canada licence approval for diabetes screening device
    VeraLight Inc. announced its Scout DS device was granted a Health Canada Medical Device Licence for non-invasive diabetes screening. The device needs no blood and does not require fasting. The patient simply places their forearm onto the portable table-top unit and a quantitative result is reported in about three minutes.
    Read more

  • MedShape wins CE Mark certification for soft tissue fixation devices
    MedShape Solutions Inc., the industry leader in innovative shape memory orthopedic devices, announced that it has been notified of CE Mark approval for the Morphix Anchor and the ExoShape Interference Fixation Device. The company has begun discussions with third party distributors across the region.
    Read more

  • Reverse Medical wins 510(k) clearance for distal intracranial catheter
    Reverse Medical Corp. received FDA 510(k) clearance to market the ReFlex line of intracranial catheters for distal neurovascular access and microcatheter therapeutic delivery. The ReFlex Catheter is uniquely designed to provide endovascular intracranial access during interventional neurovascular procedures.
    Read more

  • Guided Therapeutics FDA meeting on PMA for cervical cancer test "productive"
    Guided Therapeutics Inc. (OTC:GTHP), announced that it held a productive meeting with FDA officials to review the company’s pre-market approval application (PMA) for its non-invasive test for the early detection of cervical pre-cancer. During the meeting with FDA reviewers, which was requested by Guided Therapeutics, company representatives outlined proposed responses to recent FDA questions regarding the PMA application and also held discussions regarding proposed claims for use for the technology.
    Read more

  • Japanese firm’s Alzheimer’s skin patch falls short of FDA approval
    Eisai Co. Ltd. (TYO:4523) announced that its partner Teikoku Pharma USA Inc. received a Complete Response Letter from the FDA concerning the New Drug Application (NDA) it submitted for a transdermal patch formulation of Aricept (donepezil hydrochloride). The FDA issues a Complete Response Letter to indicate the review cycle of an application is complete and there are still requirements to be fulfilled. The requirements of FDA are mainly formulation and usage　Eisai and Teikoku USA will work with FDA to assess the Complete Response Letter and determine next steps.
    Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • New results detail J&J Embotrap design’s first-pass performance in stroke patients
    Johnson & Johnson (NYSE:JNJ) has released results for its Embotrap stent retrievers showing the next-generation design’s success in removing blood clots from ischemic stroke patients. Johnson & Johnson MedTech’s Cerenovus subsidiary tracked outcomes for 1,000 ischemic stroke patients who underwent mechanical thrombectomy procedures with Embotrap devices as a first-line therapy. “The positive preliminary findings of… […]
  • Cardinal Health expands single-use device reprocessing facility
    Cardinal Health (NYSE:CAH) recently opened its expanded Sustainable Technologies facility in Riverview, Florida. The facility is now twice as large as before, at 100,000 square feet, said Dublin, Ohio-based Cardinal Health. The medical device manufacturer and distributor launched Sustainable Technologies in 2015 to collect, reprocess and recycle single-use devices in the U.S. Sustainable Technologies now… […]
  • A new mechanically active adhesive fights muscle atrophy
    Harvard bioengineers have created a mechanically active adhesive that can prevent muscle wasting and support atrophy recovery. They call it MAGENTA, an acronym for mechanically active gel–elastomer–nitinol tissue adhesive. Researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering and Applied Sciences successfully tested… […]
  • November 2022 Issue: 2022 Medical Device Handbook
      Medtronic, Abbott and ResMed see healthcare improving through ecosystems DermaSensor aims to expand access to accurate skin cancer detection How J&J’s Embotrap stent retriever thrombectomy treats ischemic strokes Design challenges to overcome when developing cardiac ablation devices How Medtronic designed the next generation of GI bleeding treatment Innovate together Medical devices have never been… […]
  • Could minimally invasive neuromod tackle the opioid epidemic?
    Officials at Spark Biomedical and AcuityMD think their partnership could accelerate the commercialization of Spark’s potentially game-changing platform. Spark Biomedical develops a topical, minimally invasive medical device for alleviating opioid withdrawal symptoms. AcuityMD has a platform for helping medical device companies accelerate commercial access to their products. Together, they seek to provide a pathway to… […]
  • BMP Medical appoints Michael Carignan as programs and engineering manager
    BMP Medical announced that it appointed Michael Carignan as its new programs and engineering manager. Carignan joins BMP Medical at its Sterling, Massachusetts plastic manufacturing hub facility. He brings with him more than 33 years of experience in the plastic manufacturing industry. Before BMP Medical, Carignan served as president of Wachusett Precision Tool for more… […]
  • PTI Engineered Plastics receives MedAccred plastics accreditation
    PTI Engineered Plastics recently announced that MedAccred has recognized it for its commitment to continual improvement in medical device quality. The Macomb, Michigan–based company’s MedAccred accreditation follows a successful audit. MedAccred found that the medical device contract manufacturer demonstrated an ongoing commitment to quality by satisfying customer requirements and industry specifications. The nonprofit Performance Review… […]
  • Millstone Medical Outsourcing buys MycoScience
    Millstone Medical Outsourcing has purchased MycoScience, the companies said today. Fall River, Massachusetts-based Millstone said it closed the deal on Nov. 14. Terms were not disclosed. Willington, Connecticut-based MycoScience is an ISO 13485 certified contract manufacturing organization operating out of an FDA-registered facility. The company has more than three decades of experience in medical device… […]
  • These 14 medical device inventions are the best, Time magazine says
    Fourteen medical devices ranging from patient monitoring to surgical robotics recently made it into Time magazine’s Best Inventions of 2022. For over 20 years, Time magazine has highlighted the 100 most impactful devices and ideas around the world. The list is compiled through nominations from the publication’s editors and global correspondents, with special attention to… […]
  • Why Affera’s cardiac ablation technology is worth $1B to Medtronic
    Affera started in 2014 with a simple goal that paid off when Medtronic (NYSE:MDT) bought the company for up to $1 billion this year. Achieving that goal, however, took some unconventional and sometimes difficult design choices, Affera founder and CEO Doron Harlev said. Newton, Massachusetts–based Affera’s system diagnoses, maps and treats heart arrhythmias with ablation.… […]
  • Viant expands Design & Development West Center of Excellence in California
    Viant today said it has completed the expansion of its Design & Development West Center of Excellence in Fremont, California. The facility’s footprint is now 67% larger, totaling 25,000 sf² across two buildings co-located with the company’s complex molding and assembly facility. The expansion triples the amount of ISO 8 and ISO 7 cleanroom space… […]

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy